224 related articles for article (PubMed ID: 20214530)
41. Intestinal solubility and absorption of poorly water soluble compounds: predictions, challenges and solutions.
Fagerberg JH; Bergström CA
Ther Deliv; 2015; 6(8):935-59. PubMed ID: 26316058
[TBL] [Abstract][Full Text] [Related]
42. Biorelevant Drug Solubility Enhancement Modeled by a Linear Solvation Energy Relationship.
Niederquell A; Kuentz M
J Pharm Sci; 2018 Jan; 107(1):503-506. PubMed ID: 28864357
[TBL] [Abstract][Full Text] [Related]
43. The gastrointestinal stability of lipid nanocapsules.
Roger E; Lagarce F; Benoit JP
Int J Pharm; 2009 Sep; 379(2):260-5. PubMed ID: 19524655
[TBL] [Abstract][Full Text] [Related]
44. Predicting pharmacokinetic food effects using biorelevant solubility media and physiologically based modelling.
Jones HM; Parrott N; Ohlenbusch G; Lavé T
Clin Pharmacokinet; 2006; 45(12):1213-26. PubMed ID: 17112297
[TBL] [Abstract][Full Text] [Related]
45. Effects of absorption-modifying excipients on jejunal drug absorption in simulated fasted and fed luminal conditions.
Roos C; Dahlgren D; Sjögren E; Sjöblom M; Hedeland M; Lennernäs H
Eur J Pharm Biopharm; 2019 Sep; 142():387-395. PubMed ID: 31306752
[TBL] [Abstract][Full Text] [Related]
46. Enhanced bioavailability of a poorly water-soluble weakly basic compound using a combination approach of solubilization agents and precipitation inhibitors: a case study.
Li S; Pollock-Dove C; Dong LC; Chen J; Creasey AA; Dai WG
Mol Pharm; 2012 May; 9(5):1100-8. PubMed ID: 22376012
[TBL] [Abstract][Full Text] [Related]
47. Human intestinal fluid layer separation: The effect on colloidal structures & solubility of lipophilic compounds.
Riethorst D; Mitra A; Kesisoglou F; Xu W; Tack J; Brouwers J; Augustijns P
Eur J Pharm Biopharm; 2018 Aug; 129():104-110. PubMed ID: 29802985
[TBL] [Abstract][Full Text] [Related]
48. Monoglyceride-based self-assembling copolymers as carriers for poorly water-soluble drugs.
Rouxhet L; Dinguizli M; Latere Dwan'isa JP; Ould-Ouali L; Twaddle P; Nathan A; Brewster ME; Rosenblatt J; Ariën A; Préat V
Int J Pharm; 2009 Dec; 382(1-2):244-53. PubMed ID: 19666096
[TBL] [Abstract][Full Text] [Related]
49. The conflict between in vitro release studies in human biorelevant media and the in vivo exposure in rats of the lipophilic compound fenofibrate.
Do TT; Van Speybroeck M; Mols R; Annaert P; Martens J; Van Humbeeck J; Vermant J; Augustijns P; Van den Mooter G
Int J Pharm; 2011 Jul; 414(1-2):118-24. PubMed ID: 21596119
[TBL] [Abstract][Full Text] [Related]
50. Postprandial changes in solubilizing capacity of human intestinal fluids for BCS class II drugs.
Clarysse S; Psachoulias D; Brouwers J; Tack J; Annaert P; Duchateau G; Reppas C; Augustijns P
Pharm Res; 2009 Jun; 26(6):1456-66. PubMed ID: 19267186
[TBL] [Abstract][Full Text] [Related]
51. Do Macrocyclic Peptide Drugs Interact with Bile Salts under Simulated Gastrointestinal Conditions?
Dening TJ; Douglas JT; Hageman MJ
Mol Pharm; 2021 Aug; 18(8):3086-3098. PubMed ID: 34255531
[TBL] [Abstract][Full Text] [Related]
52. Use of biorelevant media for assessment of a poorly soluble weakly basic drug in the form of liquisolid compacts: in vitro and in vivo study.
Badawy MA; Kamel AO; Sammour OA
Drug Deliv; 2016; 23(3):818-27. PubMed ID: 24892630
[TBL] [Abstract][Full Text] [Related]
53. Dissolution media simulating the intralumenal composition of the small intestine: physiological issues and practical aspects.
Vertzoni M; Fotaki N; Kostewicz E; Stippler E; Leuner C; Nicolaides E; Dressman J; Reppas C
J Pharm Pharmacol; 2004 Apr; 56(4):453-62. PubMed ID: 15099440
[TBL] [Abstract][Full Text] [Related]
54. Characterization of neonatal and infant enterostomy fluids - part II: Drug solubility.
de Waal T; Brouwers J; Rayyan M; Stillhart C; Vinarova L; Vinarov Z; Augustijns P
Int J Pharm; 2023 Jul; 642():123141. PubMed ID: 37321462
[TBL] [Abstract][Full Text] [Related]
55. Fluorescence investigation of a specific structure formed by aggregation of transglycosylated stevias: solubilizing effect of poorly water-soluble drugs.
Uchiyama H; Tozuka Y; Asamoto F; Takeuchi H
Eur J Pharm Sci; 2011 May; 43(1-2):71-7. PubMed ID: 21463678
[TBL] [Abstract][Full Text] [Related]
56. Biorelevant media for transport experiments in the Caco-2 model to evaluate drug absorption in the fasted and the fed state and their usefulness.
Markopoulos C; Thoenen F; Preisig D; Symillides M; Vertzoni M; Parrott N; Reppas C; Imanidis G
Eur J Pharm Biopharm; 2014 Apr; 86(3):438-48. PubMed ID: 24184673
[TBL] [Abstract][Full Text] [Related]
57. Simulating fasted human intestinal fluids: understanding the roles of lecithin and bile acids.
Söderlind E; Karlsson E; Carlsson A; Kong R; Lenz A; Lindborg S; Sheng JJ
Mol Pharm; 2010 Oct; 7(5):1498-507. PubMed ID: 20698569
[TBL] [Abstract][Full Text] [Related]
58. High throughput UV method for the estimation of thermodynamic solubility and the determination of the solubility in biorelevant media.
Bard B; Martel S; Carrupt PA
Eur J Pharm Sci; 2008 Mar; 33(3):230-40. PubMed ID: 18207706
[TBL] [Abstract][Full Text] [Related]
59. Biorelevant media simulating fed state intestinal fluids: colloid phase characterization and impact on solubilization capacity.
Kleberg K; Jacobsen F; Fatouros DG; Müllertz A
J Pharm Sci; 2010 Aug; 99(8):3522-32. PubMed ID: 20564382
[TBL] [Abstract][Full Text] [Related]
60. Dissolution-modulating mechanism of pH modifiers in solid dispersion containing weakly acidic or basic drugs with poor water solubility.
Tran PH; Tran TT; Lee KH; Kim DJ; Lee BJ
Expert Opin Drug Deliv; 2010 May; 7(5):647-61. PubMed ID: 20205605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
